Author

Rucheng Yan

Institutions: Tongji University, Shanghai East Hospital

Observed institutions: Wannan Medical College, Tongji University, Shanghai Medical College of Fudan University, Shanghai Jiao Tong University, Fudan University, Shanghai Ninth People's Hospital, Shanghai East Hospital, First Affiliated Hospital of Wannan Medical College

ORCID: 0000-0002-2100-2166

Observed ORCID: 0000-0002-2100-2166

OpenAlex ID: A5042840967

Overcoming therapeutic resistance in oncolytic herpes virotherapy by targeting IGF2BP3-induced NETosis in malignant glioma

2024 · Weiwei Dai, Ruotong Tian, et al. · Nature Communications · 72

NSUN5/TET2-directed chromatin-associated RNA modification of 5-methylcytosine to 5-hydroxymethylcytosine governs glioma immune evasion

2024 · Ruixin Wu, Chunming Sun, et al. · Proceedings of the National Academy of Sciences · 56

Therapeutic targeting m6A-guided miR-146a-5p signaling contributes to the melittin-induced selective suppression of bladder cancer

2022 · Rucheng Yan, Weiwei Dai, et al. · Cancer Letters · 56

Melittin inhibits tumor cell migration and enhances cisplatin sensitivity by suppressing IL‐17 signaling pathway gene LCN2 in castration‐resistant prostate cancer

2023 · Rucheng Yan, Weiwei Dai, et al. · The Prostate · 18

Nanosecond pulsed electric fields combined with stem cell inhibition for the treatment of benign prostatic hyperplasia

2026 · Peixuan Wu, Wang Ran, et al. · Bioelectrochemistry

A polysynaptic hypothalamus–pelvic ganglion circuit regulates prostate tumor growth via WNT3A

2026 · Wang Ran, Peixuan Wu, et al. · bioRxiv (Cold Spring Harbor Laboratory)

Melittin enhances PD-L1 blockade in prostate cancer by inhibiting M2 macrophage polarization and recruitment

2026 · Rucheng Yan, Kejia Zhang, et al. · World Journal of Surgical Oncology

Works count: 7

Citation count: 202

H-index: 4

I10-index: 4